[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Hepatitis B Vaccine Market Report 2016

November 2016 | 110 pages | ID: U3BF3531064EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Hepatitis B Vaccine

Revenue, means the sales value of Hepatitis B Vaccine

This report studies sales (consumption) of Hepatitis B Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • GSK
  • Merck
  • Sanofi-Pasteur
  • Novartis
  • BE
  • CSL Behring
  • LG Life Sciences
  • Crucell
  • Berna
  • TIANTAN BIO
  • BIO KANGTAI
  • Hissen
  • NCPC GeneTech
  • HUALAN BIO
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Blood Type
  • GM Type
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Hepatitis B Vaccine in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States Hepatitis B Vaccine Market Report 2016

1 HEPATITIS B VACCINE OVERVIEW

1.1 Product Overview and Scope of Hepatitis B Vaccine
1.2 Classification of Hepatitis B Vaccine
  1.2.1 Blood Type
  1.2.2 GM Type
  1.2.3 Type III
1.3 Application of Hepatitis B Vaccine
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Hepatitis B Vaccine (2011-2021)
  1.4.1 United States Hepatitis B Vaccine Sales and Growth Rate (2011-2021)
  1.4.2 United States Hepatitis B Vaccine Revenue and Growth Rate (2011-2021)

2 UNITED STATES HEPATITIS B VACCINE COMPETITION BY MANUFACTURERS

2.1 United States Hepatitis B Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Hepatitis B Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Hepatitis B Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Hepatitis B Vaccine Market Competitive Situation and Trends
  2.4.1 Hepatitis B Vaccine Market Concentration Rate
  2.4.2 Hepatitis B Vaccine Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES HEPATITIS B VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Hepatitis B Vaccine Sales and Market Share by Type (2011-2016)
3.2 United States Hepatitis B Vaccine Revenue and Market Share by Type (2011-2016)
3.3 United States Hepatitis B Vaccine Price by Type (2011-2016)
3.4 United States Hepatitis B Vaccine Sales Growth Rate by Type (2011-2016)

4 UNITED STATES HEPATITIS B VACCINE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Hepatitis B Vaccine Sales and Market Share by Application (2011-2016)
4.2 United States Hepatitis B Vaccine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES HEPATITIS B VACCINE MANUFACTURERS PROFILES/ANALYSIS

5.1 GSK
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Hepatitis B Vaccine Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 GSK Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Merck
  5.2.2 Hepatitis B Vaccine Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Merck Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Sanofi-Pasteur
  5.3.2 Hepatitis B Vaccine Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Sanofi-Pasteur Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Novartis
  5.4.2 Hepatitis B Vaccine Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Novartis Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 BE
  5.5.2 Hepatitis B Vaccine Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 BE Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 CSL Behring
  5.6.2 Hepatitis B Vaccine Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 CSL Behring Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 LG Life Sciences
  5.7.2 Hepatitis B Vaccine Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 LG Life Sciences Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Crucell
  5.8.2 Hepatitis B Vaccine Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Crucell Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Berna
  5.9.2 Hepatitis B Vaccine Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Berna Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 TIANTAN BIO
  5.10.2 Hepatitis B Vaccine Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 TIANTAN BIO Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 BIO KANGTAI
5.12 Hissen
5.13 NCPC GeneTech
5.14 HUALAN BIO

6 HEPATITIS B VACCINE MANUFACTURING COST ANALYSIS

6.1 Hepatitis B Vaccine Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Hepatitis B Vaccine

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Hepatitis B Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Hepatitis B Vaccine Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES HEPATITIS B VACCINE MARKET FORECAST (2016-2021)

10.1 United States Hepatitis B Vaccine Sales, Revenue Forecast (2016-2021)
10.2 United States Hepatitis B Vaccine Sales Forecast by Type (2016-2021)
10.3 United States Hepatitis B Vaccine Sales Forecast by Application (2016-2021)
10.4 Hepatitis B Vaccine Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Hepatitis B Vaccine
Table Classification of Hepatitis B Vaccine
Figure United States Sales Market Share of Hepatitis B Vaccine by Type in 2015
Figure Blood Type Picture
Figure GM Type Picture
Table Application of Hepatitis B Vaccine
Figure United States Sales Market Share of Hepatitis B Vaccine by Application in 2015
Figure United States Hepatitis B Vaccine Sales and Growth Rate (2011-2021)
Figure United States Hepatitis B Vaccine Revenue and Growth Rate (2011-2021)
Table United States Hepatitis B Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Hepatitis B Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Hepatitis B Vaccine Sales Share by Manufacturers
Figure 2016 Hepatitis B Vaccine Sales Share by Manufacturers
Table United States Hepatitis B Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Hepatitis B Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Hepatitis B Vaccine Revenue Share by Manufacturers
Table 2016 United States Hepatitis B Vaccine Revenue Share by Manufacturers
Table United States Market Hepatitis B Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Hepatitis B Vaccine Average Price of Key Manufacturers in 2015
Figure Hepatitis B Vaccine Market Share of Top 3 Manufacturers
Figure Hepatitis B Vaccine Market Share of Top 5 Manufacturers
Table United States Hepatitis B Vaccine Sales by Type (2011-2016)
Table United States Hepatitis B Vaccine Sales Share by Type (2011-2016)
Figure United States Hepatitis B Vaccine Sales Market Share by Type in 2015
Table United States Hepatitis B Vaccine Revenue and Market Share by Type (2011-2016)
Table United States Hepatitis B Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Hepatitis B Vaccine by Type (2011-2016)
Table United States Hepatitis B Vaccine Price by Type (2011-2016)
Figure United States Hepatitis B Vaccine Sales Growth Rate by Type (2011-2016)
Table United States Hepatitis B Vaccine Sales by Application (2011-2016)
Table United States Hepatitis B Vaccine Sales Market Share by Application (2011-2016)
Figure United States Hepatitis B Vaccine Sales Market Share by Application in 2015
Table United States Hepatitis B Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States Hepatitis B Vaccine Sales Growth Rate by Application (2011-2016)
Table GSK Basic Information List
Table GSK Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GSK Hepatitis B Vaccine Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Hepatitis B Vaccine Sales Market Share (2011-2016)
Table Sanofi-Pasteur Basic Information List
Table Sanofi-Pasteur Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi-Pasteur Hepatitis B Vaccine Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Hepatitis B Vaccine Sales Market Share (2011-2016)
Table BE Basic Information List
Table BE Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table BE Hepatitis B Vaccine Sales Market Share (2011-2016)
Table CSL Behring Basic Information List
Table CSL Behring Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table CSL Behring Hepatitis B Vaccine Sales Market Share (2011-2016)
Table LG Life Sciences Basic Information List
Table LG Life Sciences Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table LG Life Sciences Hepatitis B Vaccine Sales Market Share (2011-2016)
Table Crucell Basic Information List
Table Crucell Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Crucell Hepatitis B Vaccine Sales Market Share (2011-2016)
Table Berna Basic Information List
Table Berna Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Berna Hepatitis B Vaccine Sales Market Share (2011-2016)
Table TIANTAN BIO Basic Information List
Table TIANTAN BIO Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table TIANTAN BIO Hepatitis B Vaccine Sales Market Share (2011-2016)
Table BIO KANGTAI Basic Information List
Table BIO KANGTAI Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table BIO KANGTAI Hepatitis B Vaccine Sales Market Share (2011-2016)
Table Hissen Basic Information List
Table Hissen Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hissen Hepatitis B Vaccine Sales Market Share (2011-2016)
Table NCPC GeneTech Basic Information List
Table NCPC GeneTech Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table NCPC GeneTech Hepatitis B Vaccine Sales Market Share (2011-2016)
Table HUALAN BIO Basic Information List
Table HUALAN BIO Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table HUALAN BIO Hepatitis B Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hepatitis B Vaccine
Figure Manufacturing Process Analysis of Hepatitis B Vaccine
Figure Hepatitis B Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Hepatitis B Vaccine Major Manufacturers in 2015
Table Major Buyers of Hepatitis B Vaccine
Table Distributors/Traders List
Figure United States Hepatitis B Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States Hepatitis B Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States Hepatitis B Vaccine Production Forecast by Type (2016-2021)
Table United States Hepatitis B Vaccine Consumption Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories